推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

[HTML] from ascopubs.orgEA Perez, EH Romond, VJ Suman… - Journal of Clinical …, 2011 - jco.ascopubs.org
Purpose Trastuzumab is a humanized monoclonal antibody against the human epidermal growth
factor receptor 2 (HER2). The clinical benefits of adjuvant trastuzumab have been demonstrated
in interim analyses of four large trials. Initial data of the combined analysis of the North ...
[HTML] from jacccardiovascularinterventions.comC Spaulding, E Teiger, P Commeau… - JACC …, 2011 - interventions.onlinejacc.org
Background: Concern over the safety of drug-eluting stents implanted during PCI for STEMI
remains, and long-term follow-up from randomized trials are necessary. TYPHOON (Trial to assess
the use of the cYPHer sirolimus-eluting stent in acute myocardial infarction treated with ...
Cited by 5 - Related articles - All 4 versions
[HTML] from thelancet.comL Gianni, U Dafni, RD Gelber, E Azambuja… - The Lancet …, 2011 - Elsevier
The HERA trial is an international, multicentre, randomised, open-label, phase 3 trial comparing
treatment with trastuzumab for 1 and 2 years with observation after standard neoadjuvant, adjuvant
chemotherapy, or both in patients with HER2-positive early breast cancer. The primary ...
Cited by 7 - Related articles - All 7 versions
MA Vink, MT Dirksen, MJ Suttorp… - JACC …, 2011 - interventions.onlinejacc.org
Background: In primary percutaneous coronary intervention for acute ST-segment elevation myocardial
infarction (STEMI), the use of drug-eluting stents (DES) is still controversial. Several randomized
controlled trials of DES, compared with bare-metal stents (BMS), with short-term follow-up ...
Cited by 5 - Related articles - All 4 versions
S Saito, R Prpic, JJ Popma, J Alexander… - Cardiovascular …, 2011 - Elsevier
Angiographic and clinical outcomes associated with coronary stents eluting the new molecular
entity zotarolimus have been well characterized in a variety of geographies and patient
subsets. The Endeavor Japan study is the first prospective clinical trial to evaluate the ...
Related articles - All 3 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

增值电信业务经营许可证:沪B2-20211595

礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451